CStone Pharmaceuticals Reports 2023 Annual Results and Business Updates
- Written by PR Newswire
- Total revenue for 2023 was RMB463.8 million, with commercial revenue of RMB 368.1 million
- Healthy financial position with cash reserves of RMB 1,026.7 million as of December 31, 2023 and net loss narrowed by 57% from the past year
- CStone established strategic collaborations with multiple companies to maximize commercialization efficiency...
